APA (7th ed.) Citation

Antonacci, A., Masi, A., Vedi, V., Colella, S., Musella, F., Fiorentino, G., & Scognamiglio, V. (2026). CRISPR-Cas Technology Turns Chlamydomonas reinhardtii into a Flagship for Algal Biotechnology. Marine Drugs, 24(1), 1. https://doi.org/10.3390/md24010001

Chicago Style (17th ed.) Citation

Antonacci, Amina, Annalisa Masi, Vincenzo Vedi, Sara Colella, Federica Musella, Gabriella Fiorentino, and Viviana Scognamiglio. "CRISPR-Cas Technology Turns Chlamydomonas Reinhardtii into a Flagship for Algal Biotechnology." Marine Drugs 24, no. 1 (2026): 1. https://doi.org/10.3390/md24010001.

MLA (9th ed.) Citation

Antonacci, Amina, et al. "CRISPR-Cas Technology Turns Chlamydomonas Reinhardtii into a Flagship for Algal Biotechnology." Marine Drugs, vol. 24, no. 1, 2026, p. 1, https://doi.org/10.3390/md24010001.